Recent Finacing
Recent Raise
ILiAD Biotechnologies is an advanced clinical-stage biotech developing BPZE1, a live attenuated intranasal vaccine aimed at preventing Bordetella pertussis infection, disease, and transmission.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at ILiAD Biotechnologies.
